Table 3 Cumulative cost of medical-care services among patients with metastatic breast cancer receiving chemotherapy
| Â | Mean (USD)(%) | |
|---|---|---|
| Â | n = 1444 | |
Inpatient | Â | Â |
   Acute hospital | 25,435 | 19.8% |
Outpatient Services* | Â | Â |
   Emergency Room | 736 | 0.6% |
   Physician Office/Hospital Outpatient |  |  |
Evaluation and Management | 2,851 | 2.2% |
Laboratory | 1,755 | 1.4% |
Radiology Diagnostic | 7,184 | 5.6% |
Radiology Therapeutic | 5,002 | 3.9% |
Nuclear Medicine | 891 | 0.7% |
Procedures Requiring Anesthesia/Sedation | 2,274 | 1.8% |
Blood & Transfusion | 176 | 0.1% |
Physical & Occupational Therapy | 318 | 0.2% |
Medical & Surgical Supplies | 841 | 0.7% |
Mental health-care | 58 | 0.0% |
Other | 10,362 | 8.1% |
Subtotal | 31,713 | 24.7% |
   Home Health/Hospice/Skilled Nursing | 1,528 | 1.2% |
   Other | 3,929 | 3.1% |
   Total | 37,886 | 29.5% |
Medication | Â | Â |
   Chemotherapy | 31,651 | 24.6% |
   G-CSF | 5,018 | 3.9% |
   ESAs | 5,644 | 4.4% |
   Pain, sedatives, antidepressants | 1,821 | 1.4% |
   Anti-infectives | 332 | 0.3% |
   Anti-emetics | 2,664 | 2.1% |
   Biphosphonates | 2,842 | 2.2% |
   Gastrointestinal | 538 | 0.4% |
   Electrolytes, Caloric, Water | 67 | 0.1% |
   Cardiovascular | 573 | 0.4% |
   Blood products & Anticoagulants | 661 | 0.5% |
   Other | 13,475 | 10.5% |
Subtotal | 65,260 | 50.8% |
TOTAL | 128,556 | 100.0% |